Biotech News
Personalis Reports Third Quarter Results
Reports Q3 clinical test volume of 13,157, clinical revenue of $4.4 million and overall revenue of $25.6 million FREMONT, Calif. --(BUSINESS WIRE)--Nov. 4, 2026-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial and operational results
